Key Dates

Related Announcements

PAR-18-772 - NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

 The purpose of this Notice is to extend the expiration date of PAR-18-772 "NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)" by one Standard Application Due Date.

 The extension of PAR-18-772 accommodates receipt of new applications on February 12, 2021, resubmission applications on March 12, 2021, and AIDS applications on May 7, 2021. PAR-18-772 will now expire on May 8, 2021.

The following section of the FOA has been changed:
Part 1. Overview Information, Key Dates

Currently reads:
Expiration Date
January 8, 2021

Revised to read (changes shown in italics):
Expiration Date
May 8, 2021

All other aspects of PAR-18-772 remain unchanged during this time.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Intramural Programmatic Issues:

Shawn Bediako, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-4796
Email: [email protected]

Extramural Programmatic Issues:

Li-Shin Huang, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0535
Email: [email protected]

Peer Review Contact(s)

Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: [email protected]

Financial/Grants Management Contact(s)

Tyrone Smith, M.S.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8053
Email: [email protected]